愛污传媒

Skip to main content

What other health conditions are weight-loss drugs being tested for?

The injectable drug Ozempic is shown Saturday, July 1, 2023, in Houston. (AP Photo/David J. Phillip, File) The injectable drug Ozempic is shown Saturday, July 1, 2023, in Houston. (AP Photo/David J. Phillip, File)
Share

Eli Lilly's blockbuster diabetes drug Mounjaro and weight-loss therapy Zepbound, as well as Novo Nordisk's rival medicines Ozempic and Wegovy, are being studied to see whether they can improve health in other ways.

The U.S. Food and Drug Administration on Friday  Novo's Wegovy for lowering the risk of stroke and heart attack in overweight or obese adults who do not have diabetes.

Below are other conditions obesity treatments are being tested against:

Alcohol addiction

A study by the University of Copenhagen's Psychiatric Centre Rigshospitalet is investigating whether semaglutide, sold as Novo's Wegovy and Ozempic, can help reduce alcohol intake in  diagnosed with alcohol use disorder and obesity.

Alzheimer's disease

Novo Nordisk has begun a  testing semaglutide in patients with early Alzheimer's disease. The study, which will enrol 1,840 patients, could reach primary completion as early as 2025.

Cardiovascular disease

Eli Lilly is testing tirzepatide, sold as Mounjaro and Zepbound, for patients  and obesity. Lilly plans to enrol about 700 people in the study, which is expected to be completed by July 2024.

Researchers at the Chinese University of Hong Kong are testing Novo's semaglutide along with the mechanical removal of clots in patients with strokes caused by the blockage of large blood vessels to the brain. The approach will be compared with standard therapy. The mid-stage  aims to recruit about 140 patients.

Chronic kidney disease

Novo's Ozempic delayed the progression of chronic kidney disease in diabetes patients, cutting the risk of death from that and major cardiac events by 24%. That was, however, below investor expectations.

Lilly's tirzepatide is being evaluated in a  of chronic kidney disease in patients with obesity. Lilly plans to enrol up to 140 participants.

Liver disease

Novo is testing semaglutide in a late-stage trial of patients with a common type of fatty liver disease called non-alcoholic steatohepatitis (NASH). The  is expected to enroll about 1,200 patients.

 helped up to 74% of patients achieve absence of the disease with no worsening of liver scarring at 52 weeks, compared with 13% of patients on placebo, in a mid-stage trial for the fatty liver disease formerly known as NASH and now called metabolic dysfunction-associated steatohepatitis, or MASH.

Neurological disorders

Researchers at the Danish Headache Centre are testing semaglutide along with a very low-calorie diet as a treatment for new-onset idiopathic intracranial hypertension, a condition associated with obesity in which blood pressure inside the head rises. The  aims to recruit about 50 patients and wrap up as early as 2025.

Sleep apnea

Lilly's tirzepatide is in  for patients with obstructive sleep apnea and obesity, including people who use respiratory devices that help keep their airways open while they sleep, as well as people who don't use such devices. The study is expected to enrol about 469 participants.

(Reporting by Patrick Wingrove in New York and Sriparna Roy in Bengaluru. Editing by Bill Berkrot and Devika Syamnath)

CTVNews.ca Top Stories

A former Alberta teacher has been sentenced to four years for sexually abusing a student.

Ontario will not allow international students in medical schools beginning in the fall of 2026, and will also cover tuition for more than 1,000 students who commit to becoming a family doctor in Ontario, Premier Doug Ford said Friday.

Here's a look at Musk's contact with Putin and why it matters

Elon Musk, the billionaire owner of major government contractor SpaceX and a key ally of Republican presidential nominee Donald Trump, has been in regular contact with Russian President Vladimir Putin for the last two years, The Wall Street Journal reported.

A Montreal man is charged with first-degree murder in connection to the stabbing death of a woman at a park in Ottawa鈥檚 south end on Thursday.

Local Spotlight

A new resident at a Manitoba animal rescue has waddled her way into people's hearts.

Hundreds of people ran to the music of German composer and pianist Beethoven Wednesday night in a unique race in Halifax.

He is a familiar face to residents of a neighbourhood just west of Roncesvalles Avenue.

A meteor lit up our region's sky last night 鈥 with a large fireball shooting across the horizon over Lake Erie at around 7:00 p.m.

Residents of Ottawa's Rideauview neighbourhood say an aggressive wild turkey has become a problem.

A man who lost his life while trying to rescue people from floodwaters, and a 13-year-old boy who saved his family from a dog attack, are among the Nova Scotians who received a medal for bravery Tuesday.

A newly minted Winnipegger is hoping a world record attempt will help bring awareness for the need for more pump track facilities in the city.

A Springfield, Ont. man is being hailed a 'hero' after running into his burning home to save his two infant children.

Hortense Anglin was the oldest graduate to make her way across the platform at York University's Fall Convocation ceremony this week. At the age of 87, she graduated with an Honours degree in Religious Studies.